All Posts

Femtech Investment Round-up (April 2021)

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is April 2021’s round-up. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet…

Presagen’s Life Whisperer: Artificial Intelligence Helps IVF Patients Avoid Invasive Embryo Genetic Testing

Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky. Presagen CEO, Dr Michelle Perugini said:…

CVS Health Launches a $100M Venture Fund

Earlier today CVS Health announced the launch of CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler. “Consumers deserve a better health experience, one that puts them at the center of cutting-edge, digitally enabled solutions,” said Karen S. Lynch, President and CEO, CVS…

A Global Team of Experts Has Defined Menstrual Health to Advance Policy, Practice, and Research

Billions of people around the world experience a menstrual cycle. Meeting their menstrual needs is essential for achieving health and gender equality. A growing body of activists and actors are rising to the challenge and have brought visibility to this long-marginalized topic. However, large-scale investment and coordination across sectors is needed to ensure menstrual health for everyone, everywhere. To provide a common…

Pregnancy Company Sera Prognostics Completes a $100 Million Series E Financing to Expand Commercialization of its PreTRM Test

Sera Prognostics, “The Pregnancy Company”, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the completion of a $100 million Series E financing. Several leading healthcare-focused institutional investors have joined this financing round, including Vivo Capital, aMoon Fund, Parian Global, and others, led by existing investors Anthem, Inc., and Blue Ox Healthcare…

What’s New in Femtech This Week? (April 29, 2021)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your…

Finance Exec Meredith Whitney Joins Kindbody as the Company’s New CFO

Kindbody today announced Meredith Whitney as its Chief Financial Officer and newest addition to its female-led executive team. Whitney joins Kindbody as a seasoned leader with a long and illustrious career in finance, having shattered the glass ceiling during her time on Wall Street. Whitney has been one of the most visible female analysts on Wall Street, earning recognition from Fortune Magazine as one…

Frost & Sullivan Awards OCON Healthcare with the 2021 Global Enabling Technology Leadership Award

Based on its recent analysis of the global intrauterine device (IUD) market, Frost & Sullivan recognizes OCON Healthcare (OCON) with the 2021 Global Enabling Technology Leadership Award for creating the world’s first and only 3D spherical copper IUD, the Intra Uterine Ball (IUB) Ballerine. The IUD is made from nitinol, a super-elastic alloy that can retain shape and is an ideal transporter of drugs to the…